677940

Arifulla Khan MD — FEI 3003114854

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 24, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bellevue, WA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance